Aquestive Therapeutics, Inc. (AQST) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 14.45M | 13.02M | 12.81M | 10M | 8.72M | 11.87M | 13.54M | 20.1M | 12.05M | 13.21M | 13M | 13.24M |
| Revenue Growth % | 65.67% | 9.67% | -5.43% | -50.23% | -27.65% | -10.14% | 4.15% | 51.79% | 8.25% | 23.63% | 13.43% | -0.18% |
| Cost of Goods Sold | 3.47M | 5.84M | 4.51M | 4.56M | 3.65M | 4.52M | 4.44M | 4.53M | 4.39M | 4.68M | 4.8M | 6.62M |
| COGS % of Revenue | 24.01% | 44.84% | 35.18% | 45.6% | 41.88% | 38.09% | 32.76% | 22.52% | 36.41% | 35.43% | 36.9% | 49.97% |
| Gross Profit | 10.98M | 7.18M | 8.3M | 5.44M | 5.07M | 7.35M | 9.11M | 15.57M | 7.66M | 8.53M | 8.2M | 6.62M |
| Gross Margin % | 75.99% | 55.16% | 64.82% | 54.4% | 58.12% | 61.91% | 67.24% | 77.48% | 63.59% | 64.57% | 63.1% | 50.03% |
| Gross Profit Growth % | 116.59% | -2.29% | -8.83% | -65.05% | -33.87% | -13.84% | 10.98% | 135.1% | 19.81% | 58.58% | 19.98% | -17.44% |
| Operating Expenses | 15.18M | 36.02M | 19.78M | 16.81M | 24.43M | 20.93M | 17.39M | 15.52M | 16.62M | 12.44M | 10.58M | 10.83M |
| OpEx % of Revenue | 105.09% | 276.74% | 154.45% | 168.05% | 280.19% | 176.34% | 128.45% | 77.21% | 137.9% | 94.18% | 81.38% | 81.81% |
| Selling, General & Admin | 10.98M | 32.82M | 15.25M | 12.71M | 19.07M | 16.01M | 12.13M | 11.36M | 10.69M | 9.55M | 7.38M | 7.36M |
| SG&A % of Revenue | 75.99% | 252.19% | 119.08% | 127.01% | 218.72% | 134.9% | 89.54% | 56.5% | 88.68% | 72.32% | 56.8% | 55.58% |
| Research & Development | 4.2M | 3.2M | 4.53M | 4.11M | 5.36M | 4.92M | 5.27M | 4.16M | 5.93M | 2.89M | 3.2M | 3.47M |
| R&D % of Revenue | 29.1% | 24.56% | 35.37% | 41.04% | 61.48% | 41.43% | 38.91% | 20.71% | 49.22% | 21.87% | 24.58% | 26.23% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.2M | -28.84M | -11.48M | -11.37M | -19.36M | -13.58M | -8.29M | 55K | -8.96M | -3.91M | -2.38M | -4.21M |
| Operating Margin % | -29.1% | -221.58% | -89.63% | -113.65% | -222.08% | -114.43% | -61.22% | 0.27% | -74.31% | -29.62% | -18.28% | -31.79% |
| Operating Income Growth % | 78.29% | -112.38% | -38.47% | -20769.09% | -116.2% | -247.2% | -248.76% | 101.31% | -94.51% | 63.49% | 73.15% | 67.02% |
| EBITDA | -4.08M | -28.71M | -11.34M | -11.23M | -19.23M | -13.43M | -8.13M | 260K | -8.75M | -3.44M | -2.12M | -3.92M |
| EBITDA Margin % | -28.28% | -220.58% | -88.55% | -112.25% | -220.48% | -113.19% | -60.04% | 1.29% | -72.6% | -26.08% | -16.31% | -29.6% |
| EBITDA Growth % | 78.75% | -113.74% | -39.47% | -4418.46% | -119.73% | -290.01% | -283.54% | 106.63% | -104.44% | 66.62% | 74.32% | 67.59% |
| D&A (Non-Cash Add-back) | 119K | 130K | 139K | 140K | 139K | 147K | 159K | 205K | 207K | 467K | 257K | 289K |
| EBIT | -4.2M | -28.84M | -11.48M | -11.37M | -19.36M | -12.85M | -7.31M | 1.45M | -8.63M | -4.78M | -863K | -4.08M |
| Net Interest Income | -3.94M | -4.27M | -4.27M | -4.28M | -4.28M | -3.49M | -3.22M | -2.8M | -3.87M | -3.07M | 202K | -1.3M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 734K | 979K | 1.4M | 329K | 165K | 1.51M | 129K |
| Interest Expense | 3.94M | 4.27M | 4.27M | 4.28M | 4.28M | 4.22M | 4.2M | 4.2M | 4.2M | 3.23M | 1.31M | 1.43M |
| Other Income/Expense | -3.85M | -3.02M | -3.97M | -2.18M | -3.56M | -3.49M | -3.22M | -2.8M | -3.87M | -4.1M | 202K | -1.3M |
| Pretax Income | -8.06M | -31.86M | -15.45M | -13.55M | -22.93M | -17.07M | -11.51M | -2.75M | -12.83M | -8.01M | -2.17M | -5.51M |
| Pretax Margin % | -55.77% | -244.79% | -120.61% | -135.44% | -262.96% | -143.84% | -84.99% | -13.66% | -106.43% | -60.65% | -16.73% | -41.6% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | -14K | 0 | 0 | 0 | 101K | -140K | 284K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0.08% | 0% | 0% | 0% | -1.26% | 6.44% | -5.16% |
| Net Income | -8.06M | -31.86M | -15.45M | -13.55M | -22.93M | -17.05M | -11.51M | -2.75M | -12.83M | -8.11M | -2.04M | -5.79M |
| Net Margin % | -55.77% | -244.79% | -120.61% | -135.44% | -262.96% | -143.72% | -84.99% | -13.66% | -106.43% | -61.42% | -15.65% | -43.74% |
| Net Income Growth % | 64.86% | -86.81% | -34.21% | -393.55% | -78.75% | -110.27% | -465.55% | 52.61% | -259% | 34.33% | 83.77% | 64.47% |
| Net Income (Continuing) | -8.06M | -31.86M | -15.45M | -13.55M | -22.93M | -17.05M | -11.51M | -2.75M | -12.83M | -8.11M | -2.04M | -5.79M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.07 | -0.26 | -0.14 | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 | -0.17 | -0.12 | -0.03 | -0.10 |
| EPS Growth % | 70.83% | -36.84% | -7.69% | -363.58% | -41.18% | -58.33% | -312.7% | 69.8% | -165.38% | 63.64% | 86.3% | 77.27% |
| EPS (Basic) | -0.07 | -0.26 | -0.14 | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 | -0.17 | -0.12 | -0.03 | -0.10 |
| Diluted Shares Outstanding | 122.61M | 121.97M | 110.58M | 99.33M | 95.5M | 91.2M | 91.08M | 90.91M | 73.61M | 68.53M | 64.68M | 57.35M |
| Basic Shares Outstanding | 122.61M | 121.97M | 110.58M | 99.33M | 95.5M | 91.2M | 91.08M | 90.91M | 73.61M | 68.53M | 64.68M | 57.35M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |